Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP

Last updated on 2019-03-01 History
Report ID 51686
Drug Identification Number 02439409
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Company Name FRESENIUS KABI CANADA LTD
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 10 mg/mL
Dosage form(s) Solution
Route of administration Epidural
Packaging size 10 mL Ampoule
ATC code N01BB
ATC description Anesthecis, local
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-06-01
Estimated end date
Actual end date 2019-02-27
Shortage status Resolved
Updated date 2019-03-01
Company comments
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2019-03-01 French Compare
v5 2019-03-01 English Compare
v4 2018-08-30 French Compare
v3 2018-08-30 English Compare
v2 2018-06-06 French Compare
v1 2018-06-06 English Compare